Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial
- 1 December 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (12) , 1421-1424
- https://doi.org/10.1016/0277-5379(86)90073-8
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Emesis due to cancer chemotherapy: Results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomitingEuropean Journal of Cancer and Clinical Oncology, 1984
- Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.BMJ, 1984
- Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy.Journal of Clinical Oncology, 1984
- Advances in anti-emetic therapyCancer Treatment Reviews, 1984
- Methodologic issues in trials of antiemetics.Journal of Clinical Oncology, 1984
- Randomized open cross-over trial between Metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomitingEuropean Journal of Cancer and Clinical Oncology, 1984
- Emesis as a Critical Problem in ChemotherapyNew England Journal of Medicine, 1981
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Methylprednisolone as an AntiemeticNew England Journal of Medicine, 1981
- Methylprednisolone as an antiemetic during cancer chemotherapy—a pilot studyGynecologic Oncology, 1980